Featuring an interview with Dr Petros Grivas about recent
advances in the use of immunotherapy for urothelial bladder cancer,
including the following topics:
Immunotherapy for Urothelial Bladder Carcinoma — Dr Grivas
(00:00)
Choice of first-line maintenance therapy for patients with
metastatic UBC; clinical experience with avelumab (1:07:55)
Duration of pembrolizumab therapy for patients with non-muscle
invasive bladder cancer (1:11:32)
Featuring the video recorded proceedings of events held in conjunction with important scientific symposia, live webcasts and closed meetings featuring the perspectives of renowned clinical investigators, these videos provide an overview of important advances in the management of a number of solid tumors and hematologic cancers.